Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024

Report Code: MD 1038 Oct, 2019, by marketsandmarkets.com

The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. However, the dearth of skilled professionals and frequent product recalls are expected to challenge market growth in the coming years.

Cardiac Rhythm Management Devices Market

MNM helped a global Cardiac Monitoring & Cardiac Rhythm Management (CM & CRM) company, in terms of innovation, to gather insight on the market potential of Holter patches and identify ~USD 50 million revenue potential by tapping into the Holter monitors market in Asian countries namely South Korea, Japan, and Australia.

Client’s Problem Statement

The client was keen to understand revenue figures of Holter Patches in APAC countries, focusing primarily on South Korea, Japan, and Australia.

MnM Approach

MNM identified key categories of Holter monitors along with companies that offer wearable patches as a part of their product portfolio. The overall commercial market is flooded with wearable, over-the-counter ECG devices that do not have accreditation from regulatory bodies such as the U.S. Food and Drug Administration (FDA). With advancements in technology, Holter monitors have transformed portable ECG devices into highly portable versions, such as wearable patches. However, tough competition exists between key manufacturers of wearable ECG devices in the market.
MNM interviewed a host of potential Holter patch providers as well as end-users at various healthcare settings, including at-home users to understand their unmet needs, possible use cases, and benefits. MNM also analyzed regulatory pathways followed for the wearable devices segment that enabled these devices to receive the approval of respective regulatory authorities.
These analyses helped the global CM & CRM company to assess the market potential of wearable Holter patches in developed nations other than the US, namely South Korea, Japan, and Australia. Furthermore, MNM also helped the client understand the factors contributing to the growth of this segment and identify possible scenarios such as preferences over the years by various end-users, launch of new technologically advanced products, defined regulatory guidelines during the forecast period. This helped the client devise a market approach strategy that included insights on regions that needed to be targeted/prioritized first.

Revenue Impact (RI)

helped the client tap into a ~USD 50 million market, with projected revenue of ~USD 2.6 million for Holter Patches and a revenue target of USD 5.6 million in 5 years.

Consult our Analyst now

Cardiac Monitoring Devices Market by Type, the resting ECG devices segment to account for the largest share of the ECG devices market in 2019

Based on type, the ECG devices market is segmented into resting ECG devices, stress ECG devices, and Holter monitors. The resting ECG devices segment is to account for the largest share of the T-ICDs devices market in 2019. The large share of this segment can be attributed to the wide applications of resting ECG in CVD management, the low cost of resting ECG devices, simplicity, easy-to-access nature, and space-efficient structure

Cardiac Monitoring Devices Market, By type, 2017 to 2024 (USD Million)

Cardiac Rhythm Management Devices Market

Cardiac Rhythm Management Devices Market, By Type, the automated external defibrillators segment is expected to grow at the highest CAGR during the forecast period

On the basis of type, the external defibrillator devices segment is segmented into manual, wearable, and automated external defibrillators. The automated external defibrillators segment is expected to register the highest CAGR during the forecast period. Ease of use, portability, increasing number of installations of this device in public places, and the growing use of home-use defibrillators are the major factors driving the growth of the market.

The CRT-D segment to account for the largest share of the T-ICDs devices market in 2019

Based on type, the T-ICDs devices market is segmented into single-chamber ICDs, dual-chamber ICDs, and biventricular ICDs/cardiac resynchronization therapy defibrillators (CRT-Ds). The CRT-Ds segment is to account for the largest share of the T-ICDs devices market in 2019. These are preferred for heart failure patients over other ICDs, as they provide protection against sudden collapses due to tachyarrhythmia. CRT-D implantation reduces the symptoms of heart failure like fatigue and shortness of breath and improves the patient’s medical condition.

By End User, the hospital segment to account for the largest share of the ECG devices market in 2019

Based on end users, the CM & CRM devices market is segmented into hospitals, clinics, & cardiac centers; ambulatory surgery centers; and other end users (which includes home care settings, public-access markets, alternate care settings, pre-hospital care settings, and research institutes). The hospitals, clinics, & cardiac centers segment accounted for the largest share of this market in 2019. The large share of this segment can be attributed to the increasing prevalence of CVDs, growing number of patient visits to physician offices for diagnosis, an increasing number of cardiac implant procedures, and the availability of reimbursement for these procedures across developed markets

Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017 to 2024 (USD Million)

Cardiac Rhythm Management Devices Market

In 2018, The APAC market is expected to grow at the highest CAGR during the forecast period

The APAC market is estimated to grow at the highest CAGR during the forecast period. Factors such as the rising prevalence of CVDs in APAC countries, which is, in turn, attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking. A study of heart disease conditions in Asia stated that the number of heart disease cases in the region is expected to increase by over 110% between 2000 and 2020.

Market Dynamics

Driver: Technological advancements

The integration of medical data with smart mobiles has emerged as a new trend in cardiac patient care. Wireless technological advancements in CM & CRM devices have led to the introduction of mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, and ambulatory event monitors. Advanced devices such as mobile PDA systems enable real-time transmission of data. Real-time cardiac monitoring provides continuous (beat-to-beat) outpatient EKG monitoring for periods ranging up to several weeks.

Ambulatory event monitors such as ECG patch monitoring devices are portable devices used to record electrical activity (ECG) and store recorded cardiac rhythm data. This data is ultimately transmitted either to a physician’s office or to a central recording station. Examples of ambulatory event monitors available in the market include mobile cardiac outpatient telemetry (MCOT) (CardioNet), Vital Signs Transmitter (Biowatch Medical), Lifestar Ambulatory Cardiac Telemetry (ACT) system (Card Guard Scientific Survival), Zio Patch system (iRhythm Technologies), and Veritι (eCardio Diagnostics).

Restraint: Increasing incidence of CIED infections

Over the years, there has been a significant increase in the adoption of cardiac implantable electronic devices (CIEDs), due to the rising prevalence of CVDs across the globe. CIEDs are associated with an increase in survival and quality of life while treating cardiac arrhythmias. However, CIED-associated infections are a major complication associated with the use of these devices. These infections result in significant morbidity and mortality as well as substantial healthcare costs. According to an article published by the NCBI, a 2014 study reported the average cost of CIED infection in the UK to be USD 51,010 (GBP 30,958) with a mean length of stay of 29.9 days. CIED infections are generally classified as pocket infections and systemic infections. These categories are not mutually exclusive, and the two forms may coexist.

CIED infections most commonly occur in patients with an implantable cardioverter defibrillator device or cardiac resynchronization therapy defibrillator device. According to the European Heart Journal, the incidence of CIED infections was 1.19% for pacemakers, 1.91% for implantable cardioverter-defibrillators, 2.18% for cardiac resynchronization therapy pacemakers (CRT-Ps), and 3.35% for CRT defibrillators (CRT-Ds). Patients receiving CRT-Ds are likely to undergo one or more device replacements, mainly for battery depletion. Differences in CRT-D longevity strongly affect replacement surgeries and overall therapy costs. While the use of recent-generation devices has reduced the cost, significant differences exist among currently available systems. The device industry is, therefore, focusing on increasing device longevity to reduce the number of replacement operations.

Challenge: Frequent product recalls

In recent years, the market has witnessed a number of product recalls mainly due to reasons related to electrical failure, connector compatibility issues, and issues pertaining to specific defibrillators. Frequent product recalls are posing a major challenge for the growth of the CM & CRM devices market.

However, strategic initiatives undertaken by manufacturers, such as the launch of improvement programs and the development of better-performance defibrillators, pacemakers, and monitors, may help address device-related complaints.

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Billion (USD)

Segments covered

CM & CRM Devices Market—CM_by type, CRM_by Type, End-User, and Region

Geographies covered

North America (US & Canada), Europe (Germany, France, UK, Italy, Spain, RoE) APAC (Japan, China, India, RoAPAC), and RoW

Companies covered

Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands) were the leading players in the CM & CRM devices market. Other major players include Asahi Kasei Corporation (Japan), MicroPort Scientific (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER (Switzerland), BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), BTL (US), AliveCor (US), CardioComm Solutions (Canada), Agatsa Software (India), iRhythm Technologies (US), EPI Mobile Health Solutions (Singapore), and Qardio (US).

Key Market Players

Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands) were the leading players in the CM & CRM devices market. Other major players include Asahi Kasei Corporation (Japan), MicroPort Scientific (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER (Switzerland), BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), BTL (US), AliveCor (US), CardioComm Solutions (Canada), Agatsa Software (India), iRhythm Technologies (US), EPI Mobile Health Solutions (Singapore), and Qardio (US).

PRODUCT LAUNCHES, 2017–2019

Sr. No.

Company

Product

Product Description

1

Mindray

BeneHeart C Series (AED)

  • Mindray launched the BeneHeart C Series AED in September 2019.
  • This new version features the ResQNavi technology, which helps to guide users through the rescue process with step-by-step animation coaching (available in selected versions) and voice prompts.
  • BeneHeart C Series delivers the first shock in less than 8 seconds, the shortest time ever.

2

MicroPort

Eno, Teo, and Oto Pacemakers

  • MicroPort launched three next-generation MR-conditional transvenous pacing systems, namely, Eno, Teo, and Oto in January 2019 in Europe.
  • All of the three pacemakers are full-body MR-conditional, allowing patients implanted with compatible leads to undergo MRI scans in either 1.5 Tesla or 3 Tesla machines, without any exclusion zones, permitting physicians to perform MRI scans on all areas of the body.
  • All these products feature the AutoMRI technology, which enables implanted pacemakers to automatically switch in and out of the MRI mode upon detection of an MR field. 

3

BTL

CardioPoint FLEXI

  • BTL launched CardioPoint FLEXI, a pocket-sized wireless ECG, in November 2018.
  • The product offers excellent ECG readability and diagnostic confidence in combination with BTL CardioPoint features, such as ST maps, a QT module, and ECG comparison.

4

Nihon Kohden

aireeg WEE-1200 Wireless EEG System

  • Nihon launched the aireeg WEE-1200 wireless electroencephalogram (EEG) system in March 2018.
  • It provides real-time patient data during long-term epilepsy monitoring, intensive care, and routine EEG environments.

5

SCHILLER

FRED easyport plus defibrillator, FRED PA-1 Online defibrillator, CARDIOVIT CS-104 ECG System, and medilog AR Holter system

  • SCHILLER launched the FRED easyport plus defibrillator, FRED PA-1 Online defibrillator, CARDIOVIT CS-104 ECG System, and medilog AR Holter system in November 2018.
  • The medilog AR Holter system detects atrial fibrillation in zero seconds.
  • CARDIOVIT CS-104 offers resting ECG with the SCHILLER ECG analysis program along with ETM Sport. It also features resting rhythm recording for up to 20 minutes as well as stress ECG.
  • FRED easyport plus weighs only 780 grams, and its small size combined with great functionality is unique in the world.

Source: Press Releases

Critical questions the report answers:

  • Who are the major market players in the cardiac monitoring and cardiac rhythm management market?
  • What are the growth trends and the largest revenue-generating region for cardiac monitoring and cardiac rhythm management?
  • How are cardiac monitoring and cardiac rhythm management products sold to customers?
  • What are the major segments in cardiac monitoring and cardiac rhythm management?
  • What are the driving, restraining, opportunistic, and challenging factors for this market?

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 21)
    1.1 Objectives of The Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Years Considered for The Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 25)
    2.1 Research Data
    2.2 Secondary Data
           2.2.1 Key Data From Secondary Sources
    2.3 Primary Data
           2.3.1 Key Data From Primary Sources
    2.4 Market Size Estimation
           2.4.1 Revenue Mapping-Based Market Estimation
    2.5 Data Triangulation
           2.5.1 Assumptions for The Study
           2.5.2 Research Limitations

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 38)
    4.1 Cardiac Monitoring and Cardiac Rhythm Management Devices: Market Overview
    4.2 Asia Pacific: Cardiac Monitoring and Cardiac Rhythm Management Devices Market Share, By End User & Country (2018)
    4.3 Cardiac Rhythm Management Devices Market, By Type (2017–2024)
    4.4 Geographic Snapshot of The Cardiac Monitoring and Cardiac Rhythm Management Devices Market

5 Market Overview (Page No. - 42)
    5.1 Introduction
    5.2 Market Dynamics: Drivers, Restraints, and Challenges
           5.2.1 Drivers
                    5.2.1.1 Increasing Incidence of Cardiovascular Disease
                    5.2.1.2 Technological Advancements
                    5.2.1.3 Increasing Investments, Funds, and Grants for Research on CM & CRM Devices
                    5.2.1.4 Growing Preference for Wearable Cardiac Devices
           5.2.2 Restraints
                    5.2.2.1 Increasing Incidence of Cied Infections
           5.2.3 Challenges
                    5.2.3.1 Dearth of Skilled Professionals With Expertise in Electrocardiography and Cardiac Rhythm Management Devices
                    5.2.3.2 Frequent Product Recalls

6 Cardiac Monitoring Devices Market, By Type (Page No. - 47)
    6.1 Introduction
    6.2 Ecg Devices
           6.2.1 Resting Ecg Devices
                    6.2.1.1 Low Cost, Ease of Use, and Simplicity Have Driven The Adoption of Resting Ecg Devices
           6.2.2 Stress Ecg Devices
                    6.2.2.1 Flexibility in Use has Driven The Demand for Stress Ecg Devices, But High Cost has Negatively Affected The Market
           6.2.3 Holter Monitors
                    6.2.3.1 Short Duration of Monitoring is A Key Restraint to Market Growth
    6.3 Implantable Loop Recorders
           6.3.1 High Cost and Limited Applications Have Hindered Demand Growth
    6.4 Mobile Cardiac Telemetry Devices
           6.4.1 Increasing Demand for Cardiac Monitoring Solutions in Home Care Settings is Propelling Market Growth
    6.5 Cardiac Output Monitoring Devices
           6.5.1 Increasing Number of Cardiac Surgeries Will Drive The Demand for Com Devices
    6.6 Event Monitors
           6.6.1 Event Monitors Market, By Type
                    6.6.1.1 Pre-Symptom Event Monitors
                               6.6.1.1.1 Large Storage Capacity of Pre-Symptom Event Monitors Makes Them Ideal for Long-Term Monitoring
                    6.6.1.2 Post-Symptom Event Monitors
                               6.6.1.2.1 Emergence of Handheld, Wireless, and Remote Monitors Will Drive Market Growth
           6.6.2 Event Monitors Market, By Technology
                    6.6.2.1 Autodetect Monitors
                               6.6.2.1.1 Autodetect Monitors are Ideal for Patients Who are Unable to Reliably Trigger Monitors
                    6.6.2.2 Manual Event Monitors
                               6.6.2.2.1 Manual Monitors Can Be Pre-Symptom Or Post-Symptom, But Rely on The Patient to Be Triggered
    6.7 Smart Ecg Monitors
           6.7.1 Lack of Data Security Hinders The Growth of The Smart Monitors Market to Some Extent

7 Cardiac Rhythm Management Devices Market, By Type (Page No. - 62)
    7.1 Introduction
    7.2 Defibrillators
           7.2.1 Implantable Cardioverter Defibrillators
                    7.2.1.1 Transvenous Implantable Cardioverter Defibrillators (T-Icds)
                               7.2.1.1.1 Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
                                             7.2.1.1.1.1 Biventricular Icds/Crt-Ds are Preferred for Heart Failure Patients
                               7.2.1.1.2 Dual-Chamber Implantable Cardioverter Defibrillators
                                             7.2.1.1.2.1 Benefits of Dual-Chamber Icds, Such as Higher Diagnostic Accuracy, Make Them Ideal for Patients With Tachycardia Episodes
                               7.2.1.1.3 Single-Chamber Implantable Cardioverter Defibrillators
                                             7.2.1.1.3.1 Launch of Mri-Compatible Single-Chamber Icds Will Drive Market Growth
                    7.2.1.2 Subcutaneous Implantable Cardioverter Defibrillators
                               7.2.1.2.1 Safety and Efficacy of S-Icds in The Prevention of Sudden Cardiac Arrest Will Boost Their Adoption
           7.2.2 External Defibrillators
                    7.2.2.1 Automated External Defibrillators
                               7.2.2.1.1 Semi-Automated External Defibrillators
                                             7.2.2.1.1.1 Semi-Automated External Defibrillators Accounted for The Largest Share of The Aeds Market in 2018
                               7.2.2.1.2 Fully Automated External Defibrillators
                                             7.2.2.1.2.1 Benefits of Fully Automatic Aeds and Higher Accuracy Will Drive Market Growth
                    7.2.2.2 Manual External Defibrillators
                               7.2.2.2.1 North America Dominates The Manual Defibrillators Market
                    7.2.2.3 Wearable Cardioverter Defibrillators
                               7.2.2.3.1 Ease of Use and The Noninvasive Nature of Wearable Cardioverter Defibrillators Will Support Market Growth
    7.3 Pacemakers
           7.3.1 Pacemakers Market, By Implantability
                    7.3.1.1 Implantable Pacemakers
                               7.3.1.1.1 Introduction of Leadless and Mri-Safe Devices has Boosted Device Popularity
                    7.3.1.2 External Pacemakers
                               7.3.1.2.1 Increasing Number of Open-Heart Surgeries Will Drive The Demand for External Pacemakers
           7.3.2 Pacemakers Market, By Type
                    7.3.2.1 Dual-Chamber Pacemakers
                               7.3.2.1.1 Dual-Chamber Pacemakers are The Most Commonly Implanted Pacemakers for Bradycardia—A Key Factor Driving Market Growth
                    7.3.2.2 Single-Chamber Pacemakers
                               7.3.2.2.1 Introduction of Leadless Pacemakers Will Stimulate Demand in This Product Segment
                    7.3.2.3 Biventricular/Crt Pacemakers
                               7.3.2.3.1 High Cost and Unfavorable Reimbursement Scenario Have Hindered Market Growth

8 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User (Page No. - 82)
    8.1 Introduction
    8.2 Hospitals, Clinics, & Cardiac Centers
           8.2.1 Growing Number of Cardiac Implant Procedures to Drive Market Growth
    8.3 Ambulatory Surgery Centers
           8.3.1 Growing Number of Ascs in The US to Drive The Adoption of CM & CRM Devices
    8.4 Other End Users

9 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Region (Page No. - 89)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 Growing Number of Fda Approvals for CM & CRM Devices to Support Market Growth in The US
           9.2.2 Canada
                    9.2.2.1 Growing Focus of Government and Private Organizations on Providing Funding for Research to Drive Market Growth
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Increasing Healthcare Expenditure to Drive Market Growth
           9.3.2 France
                    9.3.2.1 Rising Prevalence of Heart Failure to Drive The Adoption of Crt Devices in France
           9.3.3 UK
                    9.3.3.1 Rising Demand for Home-Based Cardiac Monitoring Devices to Support Market Growth
           9.3.4 Italy
                    9.3.4.1 Increasing Incidence of Atrial Fibrillation Among The Elderly Will Drive Market Growth in Italy
           9.3.5 Spain
                    9.3.5.1 Rising Awareness and Growing Device Adoption Indicate Strong Growth in The Coming Years
           9.3.6 Rest of Europe
    9.4 Asia Pacific
           9.4.1 Japan
                    9.4.1.1 High Healthcare Expenditure and Favorable Reimbursement and Insurance Coverage to Support Market Growth in Japan
           9.4.2 China
                    9.4.2.1 Rising Prevalence of Cvds and Government Support for Infrastructural Improvements Will Drive Market Growth
           9.4.3 India
                    9.4.3.1 Government Initiatives Will Propel Market Growth in India
           9.4.4 Rest of Asia Pacific
    9.5 Rest of The World

10 Competitive Landscape (Page No. - 135)
     10.1 Overview
     10.2 Market Share Analysis, 2018
     10.3 Competitive Scenario
             10.3.1 Contracts, Partnerships, & Agreements (2016–2019)
             10.3.2 Product Launches & Approvals (2016–2019)
             10.3.3 Expansions (2016–2019)
             10.3.4 Acquisitions (2016–2019)
     10.4 Competitive Leadership Mapping (2019)
             10.4.1 Vendor Inclusion Criteria
             10.4.2 Visionary Leaders
             10.4.3 Dynamic Differentiators
             10.4.4 Emerging Companies

11 Company Profiles (Page No. - 140)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     11.1 Abbott Laboratories
     11.2 Medtronic, PLC
     11.3 Boston Scientific Corporation
     11.4 GE Healthcare
     11.5 Koninklijke Philips N.V.
     11.6 Biotronik
     11.7 Asahi Kasei Corporation
     11.8 Microport Scientific Corporation
     11.9 Hill-Rom Holdings
     11.1 Nihon Kohden Corporation
     11.11 Schiller
     11.12 Biotelemetry
     11.13 ACS Diagnostics
     11.14 BPL Medical Technologies
     11.15 BTL
     11.16 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
     11.17 Lepu Medical Technology
     11.18 Shree Pacetronix
     11.19 Osypka AG
     11.2 Alivecor, Inc.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. 

12 Appendix (Page No. - 179)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’  Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (203 Tables)

Table 1 Recent Product Innovations in The CM & CRM Market
Table 2 Key Product Recalls
Table 3 Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 4 Ecg Devices & Event Monitors Market, 2017–2024 (Units)
Table 5 Ecg Devices Market, By Type, 2017–2024 (USD Million)
Table 6 Ecg Devices Market, By Region, 2017–2024 (USD Million)
Table 7 North America: Ecg Devices Market, By Country, 2017–2024 (USD Million)
Table 8 Europe: Ecg Devices Market, By Country, 2017–2024 (USD Million)
Table 9 APAC: Ecg Devices Market, By Country, 2017–2024 (USD Million)
Table 10 Resting Ecg Devices Market, By Region, 2017–2024 (USD Million)
Table 11 Stress Ecg Devices Market, By Region, 2017–2024 (USD Million)
Table 12 Holter Monitors Market, By Region, 2017–2024 (USD Million)
Table 13 Implantable Loop Recorders Market, By Region, 2017–2024 (USD Million)
Table 14 North America: Implantable Loop Recorders Market, By Country, 2017–2024 (USD Million)
Table 15 Europe: Implantable Loop Recorders Market, By Country, 2017–2024 (USD Million)
Table 16 APAC: Implantable Loop Recorders Market, By Country, 2017–2024 (USD Million)
Table 17 Mobile Cardiac Telemetry Devices Market, By Region, 2017–2024 (USD Million)
Table 18 Types of Com Devices
Table 19 Cardiac Output Monitoring Devices Market, By Region, 2017–2024 (USD Million)
Table 20 North America: Cardiac Output Monitoring Devices Market, By Country, 2017–2024 (USD Million)
Table 21 Europe: Cardiac Output Monitoring Devices Market, By Country, 2017–2024 (USD Million)
Table 22 APAC: Cardiac Output Monitoring Devices Market, By Country, 2017–2024 (USD Million)
Table 23 Event Monitors Market, By Region, 2017–2024 (USD Million)
Table 24 North America: Event Monitors Market, By Country, 2017–2024 (USD Million)
Table 25 Europe: Event Monitors Market, By Country, 2017–2024 (USD Million)
Table 26 APAC: Event Monitors Market, By Country, 2017–2024 (USD Million)
Table 27 Event Monitors Market, By Type, 2017–2024 (USD Million)
Table 28 Pre-Symptom Event Monitors Market, By Region, 2017–2024 (USD Million)
Table 29 Post-Symptom Event Monitors Market, By Region, 2017–2024 (USD Million)
Table 30 Indicative List of Smart Ecg Monitors
Table 31 Smart Ecg Monitors Market, By Region, 2017–2024 (USD Million)
Table 32 Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 33 Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (Units)
Table 34 Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 35 Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 36 North America: Defibrillators Market, By Country, 2017–2024(USD Million)
Table 37 Europe: Defibrillators Market, By Country, 2017–2024 (USD Million)
Table 38 APAC: Defibrillators Market, By Country, 2017–2024 (USD Million)
Table 39 Implantable Cardioverter Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 40 Implantable Cardioverter Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 41 North America: Implantable Cardioverter Defibrillators Market, By Country, 2017–2024(USD Million)
Table 42 Europe: Implantable Cardioverter Defibrillators Market, By Country, 2017–2024 (USD Million)
Table 43 APAC: Implantable Cardioverter Defibrillators Market, By Country, 2017–2024 (USD Million)
Table 44 Transvenous Implantable Cardioverter Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 45 Transvenous Implantable Cardioverter Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 46 Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 47 Dual-Chamber Implantable Cardioverter Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 48 Single-Chamber Implantable Cardioverter Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 49 Subcutaneous Implantable Cardioverter Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 50 External Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 51 External Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 52 Indicative List of Aeds That Have Received Premarket Approval From The Fda (2018–2019)
Table 53 Automated External Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 54 Automated External Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 55 Manual External Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 56 Wearable Cardioverter Defibrillators Market, By Region, 2017–2024 (USD Million)
Table 57 Pacemakers Market, By Region, 2017–2024 (USD Million)
Table 58 North America: Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 59 Europe: Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 60 APAC: Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 61 Pacemakers Market, By Implantability, 2017–2024(USD Million)
Table 62 Implantable Pacemakers Market, By Region, 2017–2024 (USD Million)
Table 63 North America: Implantable Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 64 Europe: Implantable Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 65 APAC: Implantable Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 66 External Pacemakers Market, By Region, 2017–2024 (USD Million)
Table 67 North America: External Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 68 Europe: External Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 69 APAC: External Pacemakers Market, By Country, 2017–2024 (USD Million)
Table 70 Pacemakers Market, By Type, 2017–2024 (USD Million)
Table 71 Dual-Chamber Pacemakers Market, By Region, 2017–2024 (USD Million)
Table 72 Single-Chamber Pacemakers Market, By Region, 2017–2024 (USD Million)
Table 73 Biventricular/Crt Pacemakers Market, By Region, 2017–2024 (USD Million)
Table 74 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 75 Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Hospitals, Clinics, & Cardiac Centers, By Region, 2017–2024 (USD Million)
Table 76 North America: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Hospitals, Clinics, & Cardiac Centers, By Country, 2017–2024 (USD Million)
Table 77 Europe: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Hospitals, Clinics, & Cardiac Centers, By Country, 2017–2024 (USD Million)
Table 78 APAC: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Hospitals, Clinics, & Cardiac Centers, By Country, 2017–2024 (USD Million)
Table 79 Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Ambulatory Surgery Centers, By Region, 2017–2024 (USD Million)
Table 80 North America: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Ambulatory Surgery Centers, By Country, 2017–2024 (USD Million)
Table 81 Europe: Cardiac Monitoring and Cardiac Rhythm Management  Devices Market for Ambulatory Surgery Centers, By Country, 2017–2024 (USD Million)
Table 82 APAC: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Ambulatory Surgery Centers, By Country, 2017–2024 (USD Million)
Table 83 Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 84 North America: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 85 Europe: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 86 APAC: Cardiac Monitoring and Cardiac Rhythm Management Devices Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 87 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Region, 2017–2024 (USD Million)
Table 88 Cardiac Monitoring Devices Market, By Region, 2017–2024 (USD Million)
Table 89 Cardiac Rhythm Management Devices Market, By Region, 2017–2024 (USD Million)
Table 90 North America: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Country, 2017–2024 (USD Million)
Table 91 North America: Cardiac Monitoring Devices Market, By Country, 2017–2024 (USD Million)
Table 92 North America: Cardiac Rhythm Management Devices Market, By Country, 2017–2024 (USD Million)
Table 93 North America: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 94 North America: Ecg Devices Market, By Type, 2017–2024 (USD Million)
Table 95 North America: Event Monitors Market, By Type, 2017–2024 (USD Million)
Table 96 North America: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 97 North America: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 98 North America: Implantable Cardioverter Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 99 North America: T-Icds Market, By Type, 2017–2024 (USD Million)
Table 100 North America: External Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 101 North America: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 102 North America: Pacemakers Market, By Type, 2017–2024 (USD Million)
Table 103 North America: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 104 US: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 105 US: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 106 US: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 107 US: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 108 US: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 109 Canada: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 110 Canada: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 111 Canada: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 112 Canada: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 113 Canada: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 114 Europe: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Country, 2017–2024 (USD Million)
Table 115 Europe: Cardiac Monitoring Devices Market, By Country, 2017–2024 (USD Million)
Table 116 Europe: Cardiac Rhythm Management Devices Market, By Country, 2017–2024 (USD Million)
Table 117 Europe: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 118 Europe: Ecg Devices Market, By Type, 2017–2024 (USD Million)
Table 119 Europe: Event Monitors Market, By Type, 2017–2024 (USD Million)
Table 120 Europe: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 121 Europe: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 122 Europe: Implantable Cardioverter Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 123 Europe: T-Icds Market, By Type, 2017–2024 (USD Million)
Table 124 Europe: External Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 125 Europe: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 126 Europe: Pacemakers Market, By Type, 2017–2024 (USD Million)
Table 127 Europe: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 128 Germany: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 129 Germany: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 130 Germany: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 131 Germany: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 132 Germany: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 133 France: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 134 France: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 135 France: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 136 France: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 137 France: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 138 UK: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 139 UK: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 140 UK: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 141 UK: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 142 UK: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 143 Italy: Number of Elderly Citizens With Atrial Fibrillation (In Thousands)
Table 144 Italy: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 145 Italy: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 146 Italy: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 147 Italy: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 148 Italy: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 149 Spain: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 150 Spain: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 151 Spain: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 152 Spain: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 153 Spain: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 154 RoE: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 155 RoE: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 156 RoE: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 157 RoE: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 158 RoE: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 159 APAC: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Country, 2017–2024 (USD Million)
Table 160 APAC: Cardiac Monitoring Devices Market, By Country, 2017–2024 (USD Million)
Table 161 APAC: Cardiac Rhythm Management Devices Market, By Country, 2017–2024 (USD Million)
Table 162 APAC: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 163 APAC: Ecg Devices Market, By Type, 2017–2024 (USD Million)
Table 164 APAC: Event Monitors Market, By Type, 2017–2024 (USD Million)
Table 165 APAC: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 166 APAC: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 167 APAC: Implantable Cardioverter Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 168 APAC: T-Icds Market, By Type, 2017–2024 (USD Million)
Table 169 APAC: External Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 170 APAC: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 171 APAC: Pacemakers Market, By Type, 2017–2024 (USD Million)
Table 172 APAC: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 173 Japan: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 174 Japan: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 175 Japan: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 176 Japan: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 177 Japan: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 178 China: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 179 China: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 180 China: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 181 China: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 182 China: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 183 India: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 184 India: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 185 India: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 186 India: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 187 India: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 188 RoAPAC: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 189 RoAPAC: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 190 RoAPAC Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 191 RoAPAC: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 192 RoAPAC: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)
Table 193 RoW: Cardiac Monitoring Devices Market, By Type, 2017–2024 (USD Million)
Table 194 RoW: Ecg Devices Market, By Type, 2017–2024 (USD Million)
Table 195 RoW: Event Monitors Market, By Type, 2017–2024 (USD Million)
Table 196 RoW: Cardiac Rhythm Management Devices Market, By Type, 2017–2024 (USD Million)
Table 197 RoW: Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 198 RoW: Implantable Cardioverter Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 199 RoW: T-Icds Market, By Type, 2017–2024 (USD Million)
Table 200 RoW: External Defibrillators Market, By Type, 2017–2024 (USD Million)
Table 201 RoW: Pacemakers Market, By Implantability, 2017–2024 (USD Million)
Table 202 RoW: Pacemakers Market, By Type, 2017–2024 (USD Million)
Table 203 RoW: Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2017–2024 (USD Million)


List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: CRM Devices Market
Figure 5 Market Data Triangulation Methodology
Figure 6 Cardiac Monitoring Devices Market, By Type, 2019 vs. 2024 (USD Million)
Figure 7 Transvenous Implantable Cardioverter Defibrillators Market, By Type, 2019 vs. 2024 (USD Million)
Figure 8 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User, 2019 vs. 2024
Figure 9 Geographical Snapshot of The Cardiac Monitoring and Cardiac Rhythm Management Devices Market
Figure 10 Increasing Prevalence of Cardiovascular Diseases Will Drive Market GRoWth
Figure 11 Hospitals, Clinics, & Cardiac Centers Dominated The CM & CRM Devices Market in The APAC in 2018
Figure 12 Defibrillators to Witness The Highest Growth During The Forecast Period
Figure 13 China to Register The Highest CAGR During The Forecast Period
Figure 14 Cardiac Monitoring and Cardiac Rhythm Management Devices Market: Geographic Growth Opportunities
Figure 15 North America: Cardiac Monitoring and Cardiac Rhythm Management Devices Market Snapshot
Figure 16 France: CRM Device Implantation, 2015–2018
Figure 17 APAC: Cardiac Monitoring and Cardiac Rhythm Management Devices Market Snapshot
Figure 18 Japan: Health Expenditure as A Share of Gdp, 2005–2016
Figure 19 CRM Devices Market Share Analysis, By Key Player, 2018
Figure 20 MnM Vendor Dive Comparison Matrix: CM & CRM Devices Market
Figure 21 Abbott Laboratories: Company Snapshot (2018)
Figure 22 Medtronic: Company Snapshot (2018)
Figure 23 Boston Scientific: Company Snapshot (2018)
Figure 24 GE Healthcare: Company Snapshot (2018)
Figure 25 Philips: Company Snapshot (2018)
Figure 26 Asahi Kasei: Company Snapshot (2018)
Figure 27 Microport Scientific Corporation: Company Snapshot (2018)
Figure 28 Hill-Rom Holdings: Company Snapshot (2018)
Figure 29 Nihon Kohden: Company Snapshot (2018)
Figure 30 Biotelemetry: Company Snapshot (2018)
Figure 31 Lepu Medical: Company Snapshot (2016)
Figure 32 Shree Pacetronix: Company Snapshot (2018)

The study involved two major activities in estimating the current market size of the CM and CRM devices market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary sources referred to for this research study include government sources [such as the US Census Bureau, World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), World Bank, and European Heart Rhythm Association (EHRA)]; corporate filings (such as annual reports, investor presentations, and financial statements); and trade, business, and professional associations; among others. The secondary data was collected and analyzed to arrive at the overall market size, which was further validated by primary research. Secondary research was mainly used to obtain key information about the industry’s pool of key players, market classification and segmentation according to industry trends to the bottom-most segment level, global market trends, and key developments by both public and private organizations in the CM and CRM devices market.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from core & related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

Following is the profile breakup of primary respondents:

Cardiac Rhythm Management Devices Market - By Region 2022

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the value of the global CM & CRM devices market and other dependent submarkets, as mentioned below:

  • Key players in the global CM & CRM devices market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology included the study of the annual and quarterly financial reports & regulatory filings of major market players as well as interviews with industry experts for detailed market insights.
  • All percentage shares, splits, and breakdowns for the global CM & CRM devices market were determined by using secondary sources and verified through primary sources.
  • All key macroindicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the validated and verified quantitative & qualitative data.
  • The gathered market data was consolidated and added to detailed inputs, analyzed, and presented in this report.

Data Triangulation

After arriving at the overall market size of the global CM & CRM devices market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both the demand- and supply-side participants.

Report Objectives

  • To define, describe, and forecast the cardiac monitoring and cardiac rhythm management (CM & CRM) devices market on the basis of type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size (by value) of segments with respect to four main regions (along with countries), namely, North America, Europe, the Asia Pacific, and the Rest of the World2
  • To strategically profile key players and comprehensively analyze their core competencies3
  • To track and analyze competitive developments such as acquisitions; product launches, approvals, & enhancements; partnerships, agreements, contracts, & collaborations; and R&D activities in the CM & CRM devices market
COVID-19

Get in-depth analysis of the COVID-19 impact on the Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Request For Special Pricing
Report Code
MD 1038
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home